Update on the use of meningococcal serogroup C CRM₁₉₇-conjugate vaccine (Meningitec) against meningitis.

about

Update on the use of meningococcal serogroup C CRM₁₉₇-conjugate vaccine (Meningitec) against meningitis.

Item

http://www.wikidata.org/entity/Q38631381

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Update on the use of meningoco ...... eningitec) against meningitis.

@en

type

Item

label

Update on the use of meningoco ...... eningitec) against meningitis.

@en

prefLabel

Update on the use of meningoco ...... eningitec) against meningitis.

@en

P1476

Update on the use of meningoco ...... eningitec) against meningitis.

@en

P2093

Al-Mamoon Badahdah

http://www.w3.org/2001/XMLSchema#string

Ameneh Khatami

http://www.w3.org/2001/XMLSchema#string

Harunor Rashid

http://www.w3.org/2001/XMLSchema#string

P2860

Immunogenicity of reduced dose priming schedules of serogroup C meningococcal conjugate vaccine followed by booster at 12 months in infants: open label randomised controlled trial

Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data.

Kinetics of antibody persistence following administration of a combination meningococcal serogroup C and haemophilus influenzae type b conjugate vaccine in healthy infants in the United Kingdom primed with a monovalent meningococcal serogroup C vacc

Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity

Global practices of meningococcal vaccine use and impact on invasive disease.

Evaluation of the induction of immune memory following infant immunisation with serogroup C Neisseria meningitidis conjugate vaccines--exploratory analyses within a randomised controlled trial.

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.

Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story.

Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection.

P304

9-29

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14760584.2016.1115726

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26560735

http://www.w3.org/2001/XMLSchema#string

P921

meningitis